These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 5825408)

  • 21. Induction of protective immunity to anthrax lethal toxin with a nonhuman primate adenovirus-based vaccine in the presence of preexisting anti-human adenovirus immunity.
    Hashimoto M; Boyer JL; Hackett NR; Wilson JM; Crystal RG
    Infect Immun; 2005 Oct; 73(10):6885-91. PubMed ID: 16177368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Progress on the vaccine for anthrax].
    Zhan DW; Wang P; Wang LC; Zhang ZS
    Wei Sheng Wu Xue Bao; 2005 Feb; 45(1):149-52. PubMed ID: 15847185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The controversial anthrax vaccine.
    Goldstein R
    Nurs Spectr (Wash D C); 1999 Jun; 9(11):20-1. PubMed ID: 10562219
    [No Abstract]   [Full Text] [Related]  

  • 24. [On the 100th anniversary of L. S. Tsenkovskiĭ's development of the method of producing an attenuated vaccine against anthrax].
    Diachenko SS
    Mikrobiol Zh (1978); 1984; 46(6):93-6. PubMed ID: 6443874
    [No Abstract]   [Full Text] [Related]  

  • 25. Anthrax capsule vaccine protects against experimental infection.
    Chabot DJ; Scorpio A; Tobery SA; Little SF; Norris SL; Friedlander AM
    Vaccine; 2004 Nov; 23(1):43-7. PubMed ID: 15519706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anthrax vaccine.
    Med Lett Drugs Ther; 1998 May; 40(1026):52-3. PubMed ID: 9599595
    [No Abstract]   [Full Text] [Related]  

  • 27. [Testing of an associated vaccine against anthrax and infectious ovine enterotoxemia].
    Pankratov LD; Oreshkin AS; Gorelov IuM
    Veterinariia; 1977; (2):38-9. PubMed ID: 847893
    [No Abstract]   [Full Text] [Related]  

  • 28. Anthrax vaccine development: a continuing story.
    Hambleton P; Turnbull PC
    Adv Biotechnol Processes; 1990; 13():105-22. PubMed ID: 1692223
    [No Abstract]   [Full Text] [Related]  

  • 29. A cationic lipid-formulated plasmid DNA vaccine confers sustained antibody-mediated protection against aerosolized anthrax spores.
    Hermanson G; Whitlow V; Parker S; Tonsky K; Rusalov D; Ferrari M; Lalor P; Komai M; Mere R; Bell M; Brenneman K; Mateczun A; Evans T; Kaslow D; Galloway D; Hobart P
    Proc Natl Acad Sci U S A; 2004 Sep; 101(37):13601-6. PubMed ID: 15342913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anthrax, toxins and vaccines: a 125-year journey targeting Bacillus anthracis.
    Tournier JN; Ulrich RG; Quesnel-Hellmann A; Mohamadzadeh M; Stiles BG
    Expert Rev Anti Infect Ther; 2009 Mar; 7(2):219-36. PubMed ID: 19254170
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Molecular mechanisms underlying bacillus anthracis infection at early stages and search for novel vaccines].
    Stepanov AV; Marinin LI; Staritsyn NA; Noskov AN; Borovkova LV; Kravchenko TB
    Vestn Ross Akad Med Nauk; 1997; (6):16-20. PubMed ID: 9289272
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Epidemiologic effectiveness of anthrax vaccine STI].
    Burgasov PN; Cherkasskiĭ BL; Knop AG; Utegenov KU
    Zh Mikrobiol Epidemiol Immunobiol; 1976 Sep; (9):27-35. PubMed ID: 1015076
    [No Abstract]   [Full Text] [Related]  

  • 33. Canada: Soldiers have right to refuse anthrax vaccine.
    Walker R
    Christ Sci Monitor (East Ed); 2000 May; 92(17):7. PubMed ID: 15586926
    [No Abstract]   [Full Text] [Related]  

  • 34. Cell-wall preparation containing poly-γ-D-glutamate covalently linked to peptidoglycan, a straightforward extractable molecule, protects mice against experimental anthrax infection.
    Candela T; Dumetz F; Tosi-Couture E; Mock M; Goossens PL; Fouet A
    Vaccine; 2012 Dec; 31(1):171-5. PubMed ID: 23122993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Practicalities of warfare required service personnel to be vaccinated against anthrax.
    Blain P; Lightfoot N; Bannister B
    BMJ; 1998 Oct; 317(7165):1077-8. PubMed ID: 9774304
    [No Abstract]   [Full Text] [Related]  

  • 36. Potentiation of anthrax vaccines using protective antigen-expressing viral replicon vectors.
    Wang HC; An HJ; Yu YZ; Xu Q
    Immunol Lett; 2015 Feb; 163(2):206-13. PubMed ID: 25102364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anthrax. Biological and immunological principles of diagnosis and prevention. 3. Biological, biochemical and immunological study of anthraxin.
    Shlyakhov EN; Shvarts SA
    J Hyg Epidemiol Microbiol Immunol; 1970; 14(2):139-42. PubMed ID: 5463706
    [No Abstract]   [Full Text] [Related]  

  • 38. Vaccines in civilian defense against bioterrorism.
    Russell PK
    Emerg Infect Dis; 1999; 5(4):531-3. PubMed ID: 10458959
    [No Abstract]   [Full Text] [Related]  

  • 39. Progress and novel strategies in vaccine development and treatment of anthrax.
    Chitlaru T; Altboum Z; Reuveny S; Shafferman A
    Immunol Rev; 2011 Jan; 239(1):221-36. PubMed ID: 21198675
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potentiation of an anthrax DNA vaccine with electroporation.
    Luxembourg A; Hannaman D; Nolan E; Ellefsen B; Nakamura G; Chau L; Tellez O; Little S; Bernard R
    Vaccine; 2008 Sep; 26(40):5216-22. PubMed ID: 18462850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.